Market Research Logo

Self-Monitoring Blood Glucose Devices Market Size By Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By End-User (Hospitals, Home Settings, Diagnostic Centers & Clinics), Industry Analysis Report, Regi

Self-Monitoring Blood Glucose Devices Market Size By Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By End-User (Hospitals, Home Settings, Diagnostic Centers & Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Kuwait, UAE), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Self-Monitoring Blood Glucose Devices Market will reach over USD 20 billion by 2024; as per a new research report.

Increasing diabetic population coupled with rising adoption of unhealthy dietary habits leading to increase in number of obese people will drive self-monitoring blood glucose devices market growth over the forecast timeframe. Numerous efforts undertaken by government and several other organizations to create awareness about diabetes and disease monitoring will contribute towards industry expansion.

Skyrocketing advancements and innovations in diabetes care products will propel industry growth over the forecast period. Diabetic patients are at risk of suffering from multiple chronic illnesses thereby leading to increased adoption of continuous glucose monitors to assist in real time monitoring of blood glucose levels. Programs such as National Diabetes Education Program (NDEP) undertaken by Centers for Disease Control and Prevention (CDC) in collaboration with National Institutes of Health to reduce disease burden as well as promote disease awareness will positively impact self-monitoring blood glucose devices market growth.

Growing number of health-conscious people, increasing geriatric population base prone to suffer from several chronic conditions and escalating growth of home healthcare sector has accelerated adoption rate of self-monitoring blood glucose devices. However, prohibitive cost of advanced blood glucose monitoring devices, stringent regulations and lack of favorable reimbursement policies pertaining to SMBG devices will hinder industry growth over the coming years.

Continuous glucose monitors segment is estimated to witness considerable growth during the forecast period owing to rising demand for home healthcare devices, growth of home healthcare sector and rise in number of people suffering from diabetes. Diabetic patients and elderly population generally suffer from multiple chronic disorders will stimulate industry expansion during the forecast period.

Home settings segment is anticipated to witness robust growth over the coming years owing to growth of home healthcare sector and growing demand for home healthcare devices as they are easy operative in nature and assists in continuous monitoring of blood glucose levels. Diabetic patients are increasingly opting for home healthcare blood glucose monitoring devices to avoid physician’s cost and real time monitoring of blood glucose levels.

U.S. held largest market share in 2017 and should hold its position over the coming years. Numerous efforts undertaken by government and organizations such as American Diabetes Association working towards reducing disease burden and rising awareness about diabetes monitoring will positively impact industry growth. Furthermore, technological advancements in diabetic care devices and presence of large number of industry players undertaking various strategies to gain significant market share will drive SMBG market over the forecast period.

Rising number of baby boomers susceptible to suffer from various chronic diseases coupled with high diabetic population will drive China self-monitoring blood glucose devices market over the forecast timeframe. Rising awareness about diabetes and disease monitoring has stimulated device adoption in the country, leading to business growth in China.

Few notable industry players operating in self-monitoring blood glucose devices market include Abbott Laboratories, All Medicus Co. Ltd., Arkray Inc., B. Braun Melsungen AG, Bayer Healthcare, Bionime Corporation, Dexcom Inc., F. Hoffmann-La Roche, Johnson & Johnson, LifeScan, Medtronic, Nipro Diagnostics, Nova Biomedical, Sinocare and Trividia Health. Acquisition, merger, strategic collaboration and partnership are some of the strategies adopted by industry players to broaden their product offerings and consolidate market position.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Self-monitoring blood glucose devices industry 360º synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. End-user trends
2.1.4. Regional trends
Chapter 3. Self-Monitoring Blood Glucose Devices Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024 (USD Billion)
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rising prevalence of diabetes worldwide
3.3.1.2. Technological advancements in developed countries
3.3.1.3. Government initiatives for increasing awareness among people
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of advanced devices and accessories in developing economies
3.3.2.2. Lack of reimbursement and stringent regulations for SMBG devices
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By end-user
3.5. Regulatory landscape
3.6. Porter's analysis
3.7. Company landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis
Chapter 4. Self-Monitoring Blood Glucose Devices Market, By Product
4.1. Key segment trends
4.2. Self-monitoring blood glucose meters
4.2.1. Market size by region, 2013 - 2024 (USD Million)
4.3. Continuous glucose monitors
4.3.1. Market size by region, 2013 - 2024 (USD Million)
4.4. Testing strips
4.4.1. Market size by region, 2013 - 2024 (USD Million)
4.5. Lancets
4.5.1. Market size by region, 2013 - 2024 (USD Million)
Chapter 5. Self-Monitoring Blood Glucose Devices Market, By End-User
5.1. Key segment trends
5.2. Hospitals
5.2.1. Market size, by region, 2013-2024 (USD Million)
5.3. Home settings
5.3.1. Market size, by region, 2013-2024 (USD Million)
5.4. Diagnostic centers and clinics
5.4.1. Market size, by region, 2013-2024 (USD Million)
Chapter 6. Self-Monitoring Blood Glucose Devices Market, By Region
6.1. Key regional trends
6.2. North America
6.2.1. Market size, by country, 2013 - 2024 (USD Million)
6.2.2. Market size, by product, 2013 - 2024 (USD Million)
6.2.3. Market size, by end-user, 2013 - 2024 (USD Million)
6.2.4. U.S.
6.2.4.1. Market size, by product, 2013 - 2024 (USD Million)
6.2.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.2.5. Canada
6.2.5.1. Market size, by product, 2013 - 2024 (USD Million)
6.2.5.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.3. Europe
6.3.1. Market size, by country, 2013 - 2024 (USD Million)
6.3.2. Market size, by product, 2013 - 2024 (USD Million)
6.3.3. Market size, by end-user, 2013 - 2024 (USD Million)
6.3.4. Germany
6.3.4.1. Market size, by product, 2013 - 2024 (USD Million)
6.3.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.3.5. UK
6.3.5.1. Market size, by product, 2013 - 2024 (USD Million)
6.3.5.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.3.6. France
6.3.6.1. Market size, by product, 2013 - 2024 (USD Million)
6.3.6.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.3.7. Spain
6.3.7.1. Market size, by product, 2013 - 2024 (USD Million)
6.3.7.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.3.8. Italy
6.3.8.1. Market size, by product, 2013 - 2024 (USD Million)
6.3.8.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.3.9. Russia
6.3.9.1. Market size, by product, 2013 - 2024 (USD Million)
6.3.9.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.4. Asia Pacific
6.4.1. Market size, by country, 2013 - 2024 (USD Million)
6.4.2. Market size, by product, 2013 - 2024 (USD Million)
6.4.3. Market size, by end-user, 2013 - 2024 (USD Million)
6.4.4. China
6.4.4.1. Market size, by product, 2013 - 2024 (USD Million)
6.4.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.4.5. Japan
6.4.5.1. Market size, by product, 2013 - 2024 (USD Million)
6.4.5.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.4.6. India
6.4.6.1. Market size, by product, 2013 - 2024 (USD Million)
6.4.6.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.4.7. Australia
6.4.7.1. Market size, by product, 2013 - 2024 (USD Million)
6.4.7.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.4.8. South Korea
6.4.8.1. Market size, by product, 2013 - 2024 (USD Million)
6.4.8.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.5. Latin America
6.5.1. Market size, by country, 2013 - 2024 (USD Million)
6.5.2. Market size, by product, 2013 - 2024 (USD Million)
6.5.3. Market size, by end-user, 2013 - 2024 (USD Million)
6.5.4. Brazil
6.5.4.1. Market size, by product, 2013 - 2024 (USD Million)
6.5.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.5.5. Mexico
6.5.5.1. Market size, by product, 2013 - 2024 (USD Million)
6.5.5.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.5.6. Argentina
6.5.6.1. Market size, by product, 2013 - 2024 (USD Million)
6.5.6.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.6. Middle East and Africa
6.6.1. Market size, by country, 2013 - 2024 (USD Million)
6.6.2. Market size, by product, 2013 - 2024 (USD Million)
6.6.3. Market size, by end-user, 2013 - 2024 (USD Million)
6.6.4. South Africa
6.6.4.1. Market size, by product, 2013 - 2024 (USD Million)
6.6.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.6.5. Saudi Arabia
6.6.5.1. Market size, by product, 2013 - 2024 (USD Million)
6.6.5.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.6.6. Kuwait
6.6.6.1. Market size, by product, 2013 - 2024 (USD Million)
6.6.6.2. Market size, by end-user, 2013 - 2024 (USD Million)
6.6.7. UAE
6.6.7.1. Market size, by product, 2013 - 2024 (USD Million)
6.6.7.2. Market size, by end-user, 2013 - 2024 (USD Million)
Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business overview
7.1.2. Financial data
7.1.3. Product landscape
7.1.4. Strategic outlook
7.1.5. SWOT analysis
7.2. All Medicus Co. Ltd.
7.2.1. Business overview
7.2.2. Financial data
7.2.3. Product landscape
7.2.4. Strategic outlook
7.2.5. SWOT analysis
7.3. Arkray Inc.
7.3.1. Business overview
7.3.2. Financial data
7.3.3. Product landscape
7.3.4. Strategic outlook
7.3.5. SWOT analysis
7.4. B. Braun Melsungen AG
7.4.1. Business overview
7.4.2. Financial data
7.4.3. Product landscape
7.4.4. Strategic outlook
7.4.5. SWOT analysis
7.5. Bayer Healthcare
7.5.1. Business overview
7.5.2. Financial data
7.5.3. Product landscape
7.5.4. Strategic outlook
7.5.5. SWOT analysis
7.6. Bionime Corporation
7.6.1. Business overview
7.6.2. Financial data
7.6.3. Product landscape
7.6.4. Strategic outlook
7.6.5. SWOT analysis
7.7. Dexcom Inc.
7.7.1. Business overview
7.7.2. Financial data
7.7.3. Product landscape
7.7.4. Strategic outlook
7.7.5. SWOT analysis
7.8. F. Hoffmann-La Roche
7.8.1. Business overview
7.8.2. Financial data
7.8.3. Product landscape
7.8.4. Strategic outlook
7.8.5. SWOT analysis
7.9. Johnson & Johnson
7.9.1. Business overview
7.9.2. Financial data
7.9.3. Product landscape
7.9.4. Strategic outlook
7.9.5. SWOT analysis
7.10. Lifescan
7.10.1. Business overview
7.10.2. Financial data
7.10.3. Product landscape
7.10.4. Strategic outlook
7.10.5. SWOT analysis
7.11. Medtronic
7.11.1. Business overview
7.11.2. Financial data
7.11.3. Product landscape
7.11.4. Strategic outlook
7.11.5. SWOT analysis
7.12. Nipro Diagnostics
7.12.1. Business overview
7.12.2. Financial data
7.12.3. Product landscape
7.12.4. Strategic outlook
7.12.5. SWOT analysis
7.13. Nova Biomedical
7.13.1. Business overview
7.13.2. Financial data
7.13.3. Product landscape
7.13.4. Strategic outlook
7.13.5. SWOT analysis
7.14. Sinocare
7.14.1. Business overview
7.14.2. Financial data
7.14.3. Product landscape
7.14.4. Strategic outlook
7.14.5. SWOT analysis
7.15. Trividia Health
7.15.1. Business overview
7.15.2. Financial data
7.15.3. Product landscape
7.15.4. Strategic outlook
7.15.5. SWOT analysis
Data Tables
TABLE 1. Self-monitoring blood glucose devices industry 360 degree synopsis, 2013 - 2024
TABLE 2. Global self-monitoring blood glucose devices market, 2013 - 2024 (USD Billion)
TABLE 3. Global self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 4. Global self-monitoring blood glucose devices market, by end-user, 2013 - 2024 (USD Million)
TABLE 5. Global self-monitoring blood glucose devices market, by region, 2013 - 2024 (USD Million)
TABLE 6. Industry impact forces
TABLE 7. Self-monitoring blood glucose meters market by region, 2013 - 2024 (USD Million)
TABLE 8. Continuous glucose monitors market by region, 2013 - 2024 (USD Million)
TABLE 9. Testing strips market by region, 2013 - 2024 (USD Million)
TABLE 10. Lancets market by region, 2013 - 2024 (USD Million)
TABLE 11. Hospital market by region, 2013 - 2024 (USD Million)
TABLE 12. Home settings market by region, 2013 - 2024 (USD Million)
TABLE 13. Diagnostic centers and clinics market by region, 2013 - 2024 (USD Million)
TABLE 14. North America self-monitoring blood glucose devices market, by country, 2013 - 2024 (USD Million)
TABLE 15. North America self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 16. North America self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 17. U.S. self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 18. U.S. self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 19. Canada self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 20. Canada self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 21. Europe self-monitoring blood glucose devices market, by country, 2013 - 2024 (USD Million)
TABLE 22. Europe self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 23. Europe self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 24. Germany self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 25. Germany self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 26. UK self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 27. UK self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 28. France self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 29. France self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 30. Italy self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 31. Italy self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 32. Spain self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 33. Spain self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 34. Russia self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 35. Russia self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 36. Asia Pacific self-monitoring blood glucose devices market, by country, 2013 - 2024 (USD Million)
TABLE 37. Asia Pacific self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 38. Asia Pacific self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 39. Japan self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 40. Japan self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 41. China self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 42. China self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 43. India self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 44. India self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 45. Australia self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 46. Australia self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 47. South Korea self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 48. South Korea self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 49. Latin America self-monitoring blood glucose devices market, by country, 2013 - 2024 (USD Million)
TABLE 50. Latin America self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 51. Latin America self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 52. Brazil self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 53. Brazil self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 54. Mexico self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 55. Mexico self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 56. Argentina self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 57. Argentina self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 58. MEA self-monitoring blood glucose devices market, by country, 2013 - 2024 (USD Million)
TABLE 59. MEA self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 60. MEA self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 61. South Africa self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 62. South Africa self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 63. Saudi Arabia self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 64. Saudi Arabia self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 65. Kuwait self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 66. Kuwait self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
TABLE 67. UAE self-monitoring blood glucose devices market, by product, 2013 - 2024 (USD Million)
TABLE 68. UAE self-monitoring blood glucose devices market, by end user, 2013 - 2024 (USD Million)
Charts & Figures
FIG. 1 Industry segmentation
FIG. 2 Global self-monitoring blood glucose devices market, 2013 - 2024 (USD Billion)
FIG. 3 Growth potential analysis, by product
FIG. 4 Growth potential analysis, by end-user
FIG. 5 Porter's analysis
FIG. 6 Strategy dashboard
FIG. 7 PESTEL Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report